SFI
TARO

Susquehanna Fundamental Investments’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,495
Closed -$264K – 365
2019
Q3 		$264K Sell
3,495
-3,410
-49% -$277K 0.03% 280
2019
Q2 		$590K Buy
6,905
+3,895
+129% +$385K 0.07% 238
2019
Q1 		$325K Buy
+3,010
New +$300K 0.04% 313

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna Fundamental Investments's TARO Position: Q4 2019 in Review

Susquehanna Fundamental Investments sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2019, closing a stake of 3,495 shares — an estimated $264K sold.

Susquehanna Fundamental Investments first reported a position in TARO in Q1 2019 and held it in 3 quarters. The position peaked at $590K in Q2 2019. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2019.

  • Susquehanna Fundamental Investments reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2019 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 3,495 Taro Pharmaceutical Industries Ltd. shares in Q4 2019, an estimated $264K.
  • Susquehanna Fundamental Investments first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2019 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's Taro Pharmaceutical Industries Ltd. position peaked at $590K in Q2 2019.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2019.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2019, filed 14 Feb 2020.